Research & Development

哥哥碰免费视频公开哥哥干哥哥操狠狠干哥哥干哥哥色狠狠操科创板迎开门红:16只涨幅翻倍 芯片业成最大赢家


  夏侯靜無聲的笑了一聲,指著梁贊道︰“從現在起你已經不再是老夫門下弟子,老夫會昭告天下讀書人,將你的狼心狗肺暴露在光天化日之下。”   梁贊看了夏侯衍一眼道︰“不是請不來大司農,而是,小蘭兒不允許!”哥哥碰免费视频公开 哥哥干哥哥操狠狠干   血紅,血紅的,就像是一團火。   曹襄連忙拱手道︰“正是,家母乃是大長公主劉穎。”哥哥干哥哥色狠狠操   雲瑯發現自己似乎無話可說。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo